MetLife, Inc. MET
97.70
0.45
0.46%
as of 25 Sep
- Market cap
- $61.6B
- P/E
- 18.7×
Follow MET
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
12.04% | 11.26% | 12.41% | 12.36% | |
| 0.51% | 0.45% | 0.48% | 0.47% | ||
ROIC |
10.55% | 11.21% | 11.94% | 10.65% | |
Return on Tangible Assets |
(0.91%) | (0.79%) | (0.85%) | (0.84%) | |
Average Days of Receivables |
206.53 | 235.42 | 238.93 | 234.72 | |
Free Cash Flow per Share |
22.01 | 25.55 | 23.80 | 24.21 | |
Free Cash Flow |
14,627.00 | 17,092.00 | 15,517.00 | 15,558.00 | |
Piotroski F-Score |
5.00 | 6.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
21.00% | 24.40% | 21.99% | 23.16% | |
Accounts Receivable Turnover |
1.99 | 1.93 | 1.88 | 1.91 | |
Accounts Payable Turnover |
0.24 | 0.26 | 0.26 | 0.27 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,512.14 | 1,440.32 | 1,432.19 | 1,399.06 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.22) | (0.27) | (0.25) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.89% | 2.74% | 2.79% | 2.80% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.03 | 5.39 | 4.52 | 4.52 | |
Depreciation/Fixed assets |
— | 0.00 | — | — | |
Capex/Depreciation |
— | 0.00 | — | — | |
Revenue per Share |
108.22 | 115.24 | 119.00 | 123.57 | |
Operating CF per Share |
22.01 | 25.55 | 23.80 | 24.21 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
5.05% | 4.12% | 4.43% | 4.33% |
Columns are period end dates